DuPont de Nemours, Inc. $DD Stock: Krilogy Financial LLC Increases Position

Key Points

• Krilogy Financial LLC increased its DuPont de Nemours position by 615.2% in the third quarter, purchasing 20,333 additional shares for a total holding of 23,638 shares valued at approximately $3.07 million. Institutional investors own 73.96% of the company.
• DuPont reported quarterly EPS of $1.88, beating estimates of $1.76, while revenue rose 4% year over year to $1.82 billion. The company issued third-quarter 2026 EPS guidance of $1.80–$1.90.
• Shares opened at $128.41, below their 50-day and 200-day moving averages, while analysts maintain a “Moderate Buy” consensus with an average price target of $163. DuPont also declared a quarterly dividend of $0.60 per share, representing a 1.9% yield.

Krilogy Financial LLC lifted its position in shares of DuPont de Nemours, Inc. (NYSE:DD - Free Report) by 615.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 23,638 shares of the basic materials company's stock after purchasing an additional 20,333 shares during the period. Krilogy Financial LLC's holdings in DuPont de Nemours were worth $3,070,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Nalls Sherbakoff Group LLC bought a new stake in DuPont de Nemours in the 4th quarter worth about $29,000. Elevation Wealth Partners LLC lifted its position in shares of DuPont de Nemours by 168.5% during the 2nd quarter. Elevation Wealth Partners LLC now owns 239 shares of the basic materials company's stock worth $32,000 after buying an additional 150 shares in the last quarter. Bangor Savings Bank bought a new position in shares of DuPont de Nemours during the 3rd quarter worth approximately $36,000. Grove Bank & Trust bought a new position in shares of DuPont de Nemours during the 3rd quarter worth approximately $40,000. Finally, Coastline Trust Co purchased a new position in shares of DuPont de Nemours in the 3rd quarter worth approximately $44,000. 73.96% of the stock is owned by institutional investors.

DuPont de Nemours Trading Down 0.9%

Shares of DD stock opened at $128.41 on Thursday. The company's fifty day simple moving average is $133.78 and its two-hundred day simple moving average is $138.29. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.43 and a quick ratio of 1.82. DuPont de Nemours, Inc. has a 1 year low of $97.34 and a 1 year high of $157.98. The stock has a market capitalization of $17.34 billion, a price-to-earnings ratio of 285.42, a PEG ratio of 1.18 and a beta of 1.05.

DuPont de Nemours (NYSE:DD - Get Free Report) last posted its earnings results on Tuesday, August 4th. The basic materials company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.76 by $0.12. DuPont de Nemours had a return on equity of 6.92% and a net margin of 0.67%. The firm had revenue of $1.82 billion for the quarter, compared to the consensus estimate of $1.81 billion. During the same quarter in the prior year, the business posted $1.12 earnings per share. The business's quarterly revenue was up 4.0% on a year-over-year basis. DuPont de Nemours has set its Q3 2026 guidance at 1.800-1.900 EPS. As a group, analysts anticipate that DuPont de Nemours, Inc. will post 7.26 earnings per share for the current year.

DuPont de Nemours Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, November 30th will be issued a dividend of $0.60 per share. The ex-dividend date of this dividend is Monday, November 30th. This represents a $2.40 dividend on an annualized basis and a yield of 1.9%. DuPont de Nemours's dividend payout ratio is 533.33%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on DD shares. The Goldman Sachs Group cut their target price on DuPont de Nemours from $159.00 to $153.00 and set a "neutral" rating on the stock in a research note on Wednesday, September 30th. JPMorgan Chase & Co. downgraded DuPont de Nemours from an "overweight" rating to a "neutral" rating and decreased their price target for the company from $172.00 to $145.00 in a research report on Friday, October 9th. Zacks Research lowered DuPont de Nemours from a "strong-buy" rating to a "hold" rating in a report on Friday, July 17th. Royal Bank Of Canada dropped their price target on DuPont de Nemours from $180.00 to $176.00 and set an "outperform" rating on the stock in a report on Friday, August 7th. Finally, UBS Group cut their price objective on DuPont de Nemours from $178.00 to $172.00 and set a "buy" rating on the stock in a research report on Monday, October 5th. Twelve analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $163.00.

DuPont de Nemours Company Profile

DuPont de Nemours, Inc is a science and technology company that develops engineered materials, specialty chemicals and other performance solutions for industrial and consumer markets. Its products are used in areas including electronics and semiconductor manufacturing, water purification, healthcare, transportation, construction, aerospace, worker safety and industrial processing.

DuPont's portfolio includes well-known brands and materials such as Kevlar aramid fiber, Nomex flame-resistant materials, Tyvek protective materials, Kapton polyimide film, Vespel high-performance parts and Corian solid-surface materials.

Want to see what other hedge funds are holding DD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DuPont de Nemours, Inc. (NYSE:DD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.